The comparison of plasma arsenic concentration and urinary arsenic excretion during treatment with Realgar-Indigo naturalis formula and arsenic trioxide in children with acute promyelocytic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The comparison of plasma arsenic concentration and urinary arsenic excretion during treatment with Realgar-Indigo naturalis formula and arsenic trioxide in children with acute promyelocytic leukemia

Published:2022-06-27 Issue:1 Volume:90 Page:45-52
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Liao Liu-Hua,Chen Yi-Qiao,Huang Dan-Ping,Wang Li-Na,Ye Zhong-Lu,Yang Li-Hua,Mai Hui-Rong,Li Yu,Liang Cong,Luo Jie-Si,Wang Li-Na,Luo Xue-Qun,Tang Yan-Lai,Zhang Xiao-Li,Huang Li-Bin^ORCID

Funder

The Science and Technology Planning Project of Guangdong Province, China

the Science and Technology Planning Project of Guangzhou, China

the Scientific research project of Guangdong Provincial Bureau of Traditional Chinese Medicine, China

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-022-04449-9.pdf

Reference20 articles.

1. Yang MH, Wan WQ, Luo JS et al (2018) Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG-APL clinical study. Am J Hematol 93(12):1467–1473. https://doi.org/10.1002/ajh.25271

2. Zhu HH, Wu DP, Jin J et al (2013) Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial. J Clin Oncol 31:4215–4221. https://doi.org/10.1200/JCO.2013.48.8312

3. Wang L, Zhou GB, Liu P et al (2008) Dissection of mechanisms of Chinese medicinal formula Realgar-indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA 105:4826–4831. https://doi.org/10.1073/pnas.0712365105

4. Bi LL, Ma Q, Wang SQ et al (2005) Treatment of 32 cases with recurring acute promyelocytic leukemia with tablets of composite natural indigo. Zhonghua Er Ke Za Zhi Sep 43(9):702–703. https://doi.org/10.3760/j.issn:0578-1310.2005.09.020

5. Luo XQ, Ke ZY, Huang LB et al (2009) Improved outcome for Chinese children with acute promyelocytic leukemia: a comparison of two protocols. Pediatr Blood Cancer 53(3):325–328. https://doi.org/10.1002/pbc.22042

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL group;Blood Cancer Journal;2023-12-05

2. Total urinary arsenic concentration from a pediatric patient treated witharsenic trioxide for acute promyelocytic leukemia determined by hydride generation-microwave plasma-atomic emission spectrometry;2023-10-03

3. An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications;Cell Death Discovery;2023-07-27

4. Differentiation syndrome and coagulation disorder — comparison between treatment with oral and intravenous arsenics in pediatric acute promyelocytic leukemia;Annals of Hematology;2023-05-18

5. Realgar and arsenene nanomaterials as arsenic-based anticancer agents;Current Opinion in Chemical Biology;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3